Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

A woman developed male traits from accidental contact with her husband's testosterone gel.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Too much topical minoxidil can cause excessive hair growth, but stopping treatment reverses it.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

The document concludes that various treatments, including laser therapy, are effective for managing pseudofolliculitis barbae, especially in darker skin types.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Finasteride works better for hair loss in patients 26 or younger.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Cimetidine did not reduce hair growth in women with hirsutism.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Vitamin B12 deficiency can cause skin darkening and increased blood vessels, but treatment can improve symptoms.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Young men with early hair loss have slightly worse blood sugar and fat levels, suggesting possible health risks and need for monitoring.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

Finasteride effectively lowers specific hormone levels, helping monitor treatment progress.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Spironolactone plus finasteride works better for treating hirsutism.